Clinical Predictors and Disparities in Surveillance PSA Utilization after Prostate Cancer Treatment

Guidelines recommend prostate cancer patients undergo PSA surveillance at least annually after treatment to identify disease recurrence. Few studies have assessed adherence to these recommendations, and the extent to which early post-treatment PSA values impact guideline concordance is unknown. We used the Veterans Affairs Central Cancer Registry to identify 11660 patients treated definitively for prostate cancer (surgery, radiotherapy (RT) +/-...